Table of Contents
1. Screening after Submission
Screening process will be conducted after submission. If the manuscript does not fit the aims and scope of the Journal or does not adhere to the Instructions to authors, it may be returned to the author immediately after receipt and without a review.
Before reviewing, all submitted manuscripts are inspected by Similarity Check powered by iThenticate (https://www.crossref.org/services/similarity-check/), a plagiarism-screening tool. If high degree of similarity score is found, the Editorial Board will do a more profound content screening.
The criterion for similarity rate for further screening is usually 15%; however, the excess amount of similarity in specific sentences may be also checked in every manuscript. The settings for Similarity Check screening are as follows: It excludes quotes, bibliography, small matches of 6 words, small sources of 1%, and the Methods section.
2. Peer Review Process
Submitted manuscripts will be reviewed by 2 or more experts in the corresponding field. The Editorial Board may request authors to revise the manuscripts according to the reviewer’s opinion. After revising the manuscript, the author should upload the revised files with a reply to each item of the reviewer’s opinion. The revised part should be marked as red font with underline.
The author’s revisions should be completed within 30 days after the request. If it is not received by the due date, the Editorial Board will not consider it for publication again.
The manuscript review process can be finished the second review. If further revision is requested, the Editorial Board may consider it.
The Editorial Board may request authors to correct English to reach a certain standard and authors should accept the request.
The Editorial Board will make a final decision on the approval of the submitted manuscript for publication and can request any further corrections, revisions, and deletions of the article text if necessary. Statistical editing is also performed if the data requires professional statistical review by a statistician.
3. Process after Acceptance
If the manuscript is finally accepted, the proofreading will be sent to the corresponding author after professional manuscript editing and/or English proofreading. Proofreading should be performed again for any misspellings or errors by the authors.
Before final proofreading, the manuscript may appear at the journal homepage as an epub ahead of print with a unique DOI number for rapid communication. The epub ehead of print version will be replaced by the replacement XML file and a final PDF.
4. Fee for Publication and Reprints
There is no article processing charge but an additional fee for reprints or color prints will be charged to authors. However, this policy could be changed in the future.
5. Copyright and Open access
Copyrights ownership is to be transferred to the KSCCM. The authors should submit “Authorship Responsibility and License Agreement Form” at the time of manuscript submission. This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
6. Clinical Data Sharing Policy
ACC accepts the ICMJE recommendations for data sharing statement policy (http://icmje.org/icmje-recommendations.pdf). All manuscripts reporting clinical trial results are recommended to submit a data sharing statement following the ICMJE guidelines from 1 January 2019. Authors may refer to the editorial, “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors,” in JKMS Vol. 32, No. 7:1051-1053 (http://crossmark.crossref.org/dialog/?doi=10.3346/jkms.2017.32.7.1051&domain=pdf&date_stamp=2017-06-05).